CN101618129B - Chinese medical preparation for treating rheumatoid osteopathia - Google Patents
Chinese medical preparation for treating rheumatoid osteopathia Download PDFInfo
- Publication number
- CN101618129B CN101618129B CN200910147463XA CN200910147463A CN101618129B CN 101618129 B CN101618129 B CN 101618129B CN 200910147463X A CN200910147463X A CN 200910147463XA CN 200910147463 A CN200910147463 A CN 200910147463A CN 101618129 B CN101618129 B CN 101618129B
- Authority
- CN
- China
- Prior art keywords
- medicines
- chinese
- radix
- processed
- chinese medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 25
- 239000004863 Frankincense Substances 0.000 claims abstract description 4
- 241000522620 Scorpio Species 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 239000009490 scorpio Substances 0.000 claims abstract description 4
- 238000011282 treatment Methods 0.000 claims description 20
- 208000025747 Rheumatic disease Diseases 0.000 claims description 18
- 230000000552 rheumatic effect Effects 0.000 claims description 18
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 229940126678 chinese medicines Drugs 0.000 claims description 6
- 241000131808 Scolopendra Species 0.000 claims description 4
- 241000255791 Bombyx Species 0.000 claims description 3
- 241000717739 Boswellia sacra Species 0.000 claims description 3
- 241001489978 Eupolyphaga Species 0.000 claims description 3
- 241001251068 Formica fusca Species 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 3
- 239000009286 sanguis draxonis Substances 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 241000411851 herbal medicine Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 5
- 208000026137 Soft tissue injury Diseases 0.000 abstract description 4
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 4
- 239000002775 capsule Substances 0.000 abstract description 3
- 238000003756 stirring Methods 0.000 abstract description 2
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 abstract 2
- 206010050296 Intervertebral disc protrusion Diseases 0.000 abstract 2
- 244000189799 Asimina triloba Species 0.000 abstract 1
- 235000006264 Asimina triloba Nutrition 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241001465251 Ephedra sinica Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000501743 Gentiana macrophylla Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 241000257303 Hymenoptera Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract 1
- 241001427555 Polyphaga <Blattaria> Species 0.000 abstract 1
- 241000270273 Ptyas dhumnades Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000019991 rice wine Nutrition 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 208000012287 Prolapse Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 210000000845 cartilage Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 201000003068 rheumatic fever Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010007710 Cartilage injury Diseases 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
- 206010061728 Bone lesion Diseases 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001294 Nociceptive Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical class N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- AUJRCFUBUPVWSZ-XTZHGVARSA-M auranofin Chemical compound CCP(CC)(CC)=[Au]S[C@@H]1O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O AUJRCFUBUPVWSZ-XTZHGVARSA-M 0.000 description 1
- 229960005207 auranofin Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229960001639 penicillamine Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medical preparation for treating a rheumatoid osteopathia, comprising 18 traditional Chinese medicines in proportion: zaocys dhumnade, Chinese polyphaga, scorpio, chilopod, Chinese ephedra, rhizoma atractylodis, radix cyathulae, frankincense, myrrh, batryticated silkworm, liquorice, gentiana macrophylla, pawpaw, prepared radix angelicae sinensis with yellow ricewine, eucommia bark fried by salt, blood scorpion, nux vomica and silky ants. The preparation method comprises the following steps: sieving the medicines by a fine sieve of 60-100 meshes; sufficiently stirring to evenly mix the medicines; and filling the medicines into a No.1 capsule which comprises 0.4g of crude medicines. The Chinese medical preparation is used for treating four types of diseases: lumbar intervertebral disc protrusion, rheumarthritis, rheumatoid arthritis and soft tissue injury. By clinical tests of 200 patients, the effective rate of the Chinese medical preparation for treating rheumatoid osteopathia reaches above 96 percent and has optimal effect for lumbar intervertebral disc protrusion.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of rheumatic osteopathia.Specifically, relate to a kind of Chinese patent medicine for the treatment of prolapse of lumbar intervertebral disc, rheumatic arthritis, rheumatoid arthritis and cartilage and soft tissue injury disease.
Background technology
Rheumatic osteopathia is a kind of common disease of harm humans health.Frequently-occurring disease is in mid-aged population, and, the rejuvenation year by year of falling ill in recent years.Its sickness rate height, only domestic rheumatic osteopathia patient is just up to more than 8,000 ten thousand people, and disability rate is also quite high.
In recent years, the treatment prolapse of lumbar intervertebral disc is many treats with operation method.It is big to exist operation risk, and the drawback of recurrence again after the most of patients operation; And manual reduction can't be repaired the fibrous ring and the cartilaginous tissue of destroyed again.For other rheumatic osteopathia, doctor trained in Western medicine multiselect NSAID (non-steroidal anti-inflammatory drug).As auranofin, penicillamine, immunosuppressant and adrenocortical hormone etc.The said medicine toxic and side effects is big, hepatic and renal function is formed destroy.Take for a long time and will cause the patient to make the matter worse.Though traditional Chinese medical science medicine does not have great toxic and side effects, comprise that unguentum, ball class kind are quite a few, how with collateral dredging invigorate blood circulation, reducing swelling and alleviating pain, paralysis nerve, be main at rheumatism.Acid after the drug withdrawal, expand, stiff, symptom such as take out, ache new line is arranged again, disease can not get effecting a radical cure.Specially at rheumatic osteopathia, treating both the principal and secondary aspects of a disease belongs to blank on the Chinese patent medicine that can cure.
Summary of the invention
The present invention has overcome the shortcomings and deficiencies of prior art, and a kind of Chinese medicine preparation for the treatment of rheumatic osteopathia is provided.Concrete technical scheme is summarized as follows:
A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia of the present invention, it by Zaocys, Eupolyphaga Seu Steleophaga, Scorpio, Scolopendra, Herba Ephedrae, Rhizoma Atractylodis, Radix Cyathulae, Olibanum (processed), Myrrha (processed), Bombyx Batryticatus, Radix Glycyrrhizae, Radix Gentianae Macrophyllae, this melon, Radix Angelicae Sinensis (processed with wine), Cortex Eucommiae (parched with salt), Sanguis Draxonis, Semen Strychni (processed), Formica fusca totally ten eight the flavor Chinese medicines form.
A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia of the present invention, contained 18 flavor Chinese medicines, concrete prescription is: Zaocys, Scorpio, Herba Ephedrae, Rhizoma Atractylodis (parched), Radix Cyathulae, Olibanum (processed), Myrrha (processed), Bombyx Batryticatus, Radix Glycyrrhizae, respectively account for 5～7%; Semen Strychni (processed), Radix Gentianae Macrophyllae, Fructus Chaenomelis, Sanguis Draxonis respectively account for 3～4%; Formica fusca, Cortex Eucommiae (parched with salt) respectively account for 10～13%; Radix Angelicae Sinensis (processed with wine), Eupolyphaga Seu Steleophaga respectively account for 2～4%.The total amount of 17 flavor Chinese medicines is 100%.
A kind of ratio for the treatment of the contained Scolopendra of Chinese medicine preparation of rheumatic osteopathia of the present invention is: the gross weight with all the other 17 flavor Chinese medicines is a radix, and per 100 grams add 1～2 of Scolopendra.
A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia of the present invention, concrete pharmaceutical methods is: with contained 18 flavor Chinese medicines, all be developed into powder, and mistake 60～100 mesh sieves, fully stir and make it evenly mixed, the capsule of packing into then No. 1 makes every capsules contain crude drug 0,4 grams.
A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia of the present invention, its instructions of taking and consumption are: every day 2～3 times, each 3～5, under yellow wine or eliminating cold for resuscitation water clothes.10～30 days is a course of treatment.
Compared with prior art, the invention has the beneficial effects as follows: can treat arthroncus, pain, cartilage and soft tissue pain's disease that each rheumatoid osteopathia causes effectively.Through more than 2 years to 200 routine rheumatic osteopathia patients' clinical practice, obtained curative effect preferably, obvious effective rate is up to more than 96%.Especially prolapse of lumbar intervertebral disc is had specially good effect, details are as follows for relevant clinical treatment situation:
One, among the physical data 200 routine patients, male 103 examples, women 97 examples.
Two, the age: generally between 26～64 years old, 45 years old mean age was many with person in middle and old age.Main morbidity.About 30～60 years old age.
Three, course of disease situation: two months with interior 31 examples, more than two months to 1 year 69 example, more than 1 year to 3 years 32 examples, more than 3 years to 5 years 35 examples, more than 5 years to 10 years 13 examples, 20 examples more than 10 years.
Four, typing;
1, presses the western medicine typing: rheumatic arthritis 73 examples, rheumatoid arthritis 17 examples, prolapse of lumbar intervertebral disc 96 examples, cartilage and soft tissue injury 14 examples.
2, by the Chinese medicine typing: migratory arthralgia (wind heavy type) 50 examples, arthralgia aggravated by cold (cold heavy) 74 examples, damp arthralgia (weight in wet base type) 46 examples, pyretic arthralgia (damp-heat type) 30 examples.
Five, treatment standard
1, clinical cure: pain disappears, and swelling is disappeared, joint stiff disappearance the in morning, and restore or control in the distortion joint, does not influence life, activity.
2, produce effects: pain disappears substantially, and other sign obviously alleviates.
3, invalid: as to take week back a symptom or a Signs no change or increase the weight of.
Six, curative effect is summed up:
Clinical cure 114 examples, produce effects 82 examples, invalid 4 examples, total effective rate 98%.
By the clinical practice to Chinese medicine preparation of the present invention, the treatment rheumatic osteopathia has been received satisfied curative effect.The rheumatic osteopathia symptom is a lot, and the clinical practice of this group is got rid of organic disease (as tumor) in functional category.This group selects for use clinical common prolapse of lumbar intervertebral disc, rheumatic arthritis, rheumatoid arthritis, cartilage and four types of soft tissue injury to carry out clinical treatment.Most of patients was taken the Western medicine hormone before this group case treatment, and because of toxic and side effects is stopped using, some patient carried out treatments such as the taking orally of the traditional Chinese medical science, external application, acupuncture.In taking the process of preparation of the present invention, must not take Western medicine hormone and other Chinese Traditional Medicines.
A kind of Chinese medicine preparation for the treatment of rheumatic osteopathia of the present invention has that nourishing the liver and kidney, invigorating the spleen for eliminating dampness, strengthening the tendons and bones, detumescence relieve the pain, promoting flow of qi by warming channel, dispels the effect of rheumatism, and the most effective to repairing bone lesion.The treatment rheumatic osteopathia is the most remarkable, and its effective percentage is up to more than 96%.To the prolapse of lumbar intervertebral disc best results.
Specific embodiments
Because of summary of the invention is described in detail, no longer repeat herein.
Claims (1)
1. a Chinese medicine preparation for the treatment of rheumatic osteopathia is characterized in that, it is made up of 18 flavor Chinese medicines, Zaocys wherein, and Scorpio, Herba Ephedrae, Rhizoma Atractylodis, Radix Cyathulae, Olibanum (processed), Myrrha (processed), Bombyx Batryticatus, Radix Glycyrrhizae respectively accounts for 5--7%; Semen Strychni (processed), Radix Gentianae Macrophyllae, Fructus Chaenomelis, Sanguis Draxonis respectively accounts for 3-4%; Formica fusca, Cortex Eucommiae (parched with salt) respectively account for 10-13%; Eupolyphaga Seu Steleophaga, Radix Angelicae Sinensis (processed with wine) respectively account for 2-4%, and the gross weight with above-mentioned 17 flavor Chinese herbal medicine is a radix again, and per 100 grams add Scolopendra 1-2 bar.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910147463XA CN101618129B (en) | 2009-06-09 | 2009-06-09 | Chinese medical preparation for treating rheumatoid osteopathia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910147463XA CN101618129B (en) | 2009-06-09 | 2009-06-09 | Chinese medical preparation for treating rheumatoid osteopathia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101618129A CN101618129A (en) | 2010-01-06 |
| CN101618129B true CN101618129B (en) | 2011-10-12 |
Family
ID=41511657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910147463XA Expired - Fee Related CN101618129B (en) | 2009-06-09 | 2009-06-09 | Chinese medical preparation for treating rheumatoid osteopathia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101618129B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103100077B (en) * | 2013-03-08 | 2014-12-31 | 薛春元 | Medicine for treating chronic rheumatoid bone diseases and preparation method of medicine |
| CN106176946A (en) * | 2015-05-07 | 2016-12-07 | 沈春雷 | A kind of Chinese medicine formula and preparation method thereof |
| CN106668231A (en) * | 2015-11-10 | 2017-05-17 | 马福奎 | Traditional Chinese medicine for treating protrusion of lumbar intervertebral disc |
| CN106511730A (en) * | 2017-01-03 | 2017-03-22 | 周怀明 | Prominent technology application of acupuncture in treating rheumatism bone diseases |
-
2009
- 2009-06-09 CN CN200910147463XA patent/CN101618129B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 钟秋生.补肾活血法治疗类风湿关节炎研究述要.《实用中医内科杂志》.2004,第18卷(第4期),283-285. * |
| 黄伸.中药治疗腰椎间盘突出症的研究进展.《时珍国医国药》.2004,第15卷(第12期),863-864. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101618129A (en) | 2010-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN100546644C (en) | A kind of external Chinese medicinal liquid for treating wind-cold-damp neck, shoulder, waist and leg pain | |
| CN101015651A (en) | Medicine for treating protrusion of lumbar intervertebral disc | |
| CN101618129B (en) | Chinese medical preparation for treating rheumatoid osteopathia | |
| CN100536886C (en) | A kind of traditional Chinese medicine composition for treating gout | |
| CN101214357A (en) | Pharmaceutical composition for treating chronic prostatitis | |
| CN100366279C (en) | Method for preparing traditional Chinese medicine to treat apoplexia hemiplegia and said medicine | |
| CN102085299B (en) | Chinese patent medicine for treating prostatitis and preparation method thereof | |
| CN104547961B (en) | A kind of Chinese medicine composition for treating gall stone | |
| CN1078081C (en) | Medicine for treating osteoproliferation, rheumatism and rheumatoid arthritis, and preparing method thereof | |
| CN117599125A (en) | A Chinese medicinal composition for supplementing calcium and strengthening bones for treating osteoporosis, and its preparation method and application | |
| CN104587252A (en) | Traditional Chinese medicine composition for treating kidney stones | |
| CN102836243B (en) | Traditional Chinese medicine for cure of rheumatoid arthritis | |
| CN106038881A (en) | Medicinal liquor for treating gout and preparation method of medicinal liquor | |
| CN106177002A (en) | A kind of medicated powder medicated wine complex treating bone matrix hyperplasia | |
| CN105664053A (en) | Traditional Chinese medicine composition for treating calluses on puncture of internal arteriovenous fistula of maintenance hemodialysis patient | |
| CN103751467A (en) | Traditional Chinese medicine composition for treating lumbar and back myofascitis and preparation method thereof | |
| CN112755134B (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
| CN100482259C (en) | Chinese medicine for treating cervical spondylosis | |
| CN102526544B (en) | Oral powder Chinese medicine formula for treating lumbar disc herniation and osteoproliferation | |
| CN100581578C (en) | Chinese traditional medicine capsule for healing neuropathic pain and preparing process technique thereof | |
| CN100509003C (en) | Medicament of treating psoriasis | |
| CN1424104A (en) | Medicines for treating chronic prostatitis and preparation thereof | |
| CN105998519A (en) | Oral medicine for treating frequent micturition due to pelvic inflammatory disease | |
| CN105381168A (en) | Backache relieving drug and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111012 Termination date: 20130609 |